Skip to main content

Table 1 Characteristics of patients in the intent-to-treat population

From: Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis

  ITT population
(N = 205)
HANOX-M
(N = 103)
BioHA
(N = 102)
p-value
Age (years) Mean (SD) 65.3 (10.5) 65.2 (10.1) 65.3 (10.9) 0.95
OARSI JSN Grade 1–2 N (%) 119 (58%) 57 (55.4%) 62 (60.8%) 0.68
Grade 3 N (%) 86 (42%) 46 (44.7%) 40 (39.2%)  
BMI (kg/m2) Mean (SD) 27.59 (4.92) 27.72 (5.00) 27.47 (4.86) 0.72
WOMAC A baseline Mean (SD) 9.7 (3.4) 9.7 (3.2) 9.7 (3.6) 0.98
WOMAC A endpoint Mean (SD) 5.4 (4.2) 5.4 (4.0) 5.3 (4.4) 0.95
  1. WOMAC Western Ontario & McMaster Universities Osteoarthritis Index: pain (range 0–20), OARSI OsteoArthritis Research Society International score for joint space narrowing (JSN range 0–3), BMI Body Mass Index (kg/m2)